Safe, Personalized Diagnosis & Treatments Based on Manipulations of The Natural Human Microbiome
At Biotax we’re passionate about building new innovative products that will disrupt the the Biotechnology industry. Based on novel technologies, advance science and top leading researchers.
WHO WE ARE
Biotax is a leading provider of cutting-edge technologies and services, offering biological and genomic informatics solutions for pharma companies, hospitals, and medical centers. Founded by a group of leading researchers who's mission is to help patients by creating new diagnostics and treatments protocols.
Include safe and personalized biological microbiome manipulation processes supported by cutting edge meta-genomic AI analysis platforms
PROF. NAAMA GEVA-ZATORSKY
Head of the Microbiome Lab,
The Technion, Rappaport Faculty of Medicine, Technion Integrated Cancer Center.Her research combining systems-biology with microbiology and immunology to study the interactions between gut microbes and the host immune system in health and disease. Her Ph.D from the Weizmann Institute, studying systems-biology of protein dynamics in cancer. Her postdoctoral was at Harvard Medical School, studying gut microbiota-host interactions
Co Founder, CEO
Serial entrepreneur with vast experience as founder, senior executive & business manager CEO and Co founder of BrainVu (Acquired in 2018 ). Head of the Alcatel Lucent Digital Multimedia Division (Was Spin-off and acquired by Nantworks in 2014 ). Shay worked both in startups and corporate organizations with a verity of hands-on technology leadership roles
A computational biology & SW architect expert focusing on complex multidisciplinary problems. Prior to BiotaX, Dean was software architect @Technion Data & Knowledge (TDK) Lab - the computer science faculty and developer team lead @Lamm lab - the department of biology , Technion.
Dean holds an M.Sc. in Biology and B.Sc. in both Mathematics and Computer Science from the Technion.
Dean is a recipient of the 2019 Sherman award for distinguished academic achievement in multidisciplinary research.
SARI RAHAT-ROZENBLOOM, PHD
Sari brings a variety of experience in the High-Tech industry and Life Sciences clinical research. Prior to Biotax, Sari was the Product Manager and the R&D Team Leader of Galooli. Her Ph.D. in Nutritional Sciences from the University of Toronto focused on the relations between nutrition and microbiome in diabetes and obesity.
GET IN TOUCH